Investigating the role of endogenous opioid system in chloroquine‐induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies. (25th May 2020)

• Record Type: Journal Article
• Authors: Malek, Mohammad Reza; Ahmadian, Shahin; Dehpour, Ahmad Reza; Ebrahim‐Habibi, Azadeh; Shafizadeh, Mahshid; Kashani‐Amin, Elaheh
• Is Part Of: Clinical and experimental pharmacology and physiology. Volume 47:Number 9(2020)
• Page Start: 1575
• Page End: 1583
• Publication Date: 2020-05-25
• Subjects: µ opioid receptor -- chloroquine -- endogenous opioid system -- naltrexone -- phospholipidosis; Clinical pharmacology -- Periodicals; Pharmacology, Experimental -- Periodicals; Physiology, Experimental -- Periodicals; Physiology, Pathological -- Periodicals; 615.1
• DOI: 10.1111/1440-1681.13332
• Languages: English
• ISSNs: 0305-1870

Abstract

Abstract: Drug‐induced phospholipidosis (DIPL) is characterized by phospholipid storage in the lysosomes of affected tissues. Many severe effects and toxicities have been linked to DIPL. The aim of this study was to determine whether the endogenous opioid system is involved in chloroquine‐induced phospholipidosis. The effect of naltrexone as an antagonist of opioid receptors in chloroquine‐induced phospholipidosis in rat liver was investigated by morphological, biochemical, and molecular modelling studies. Transmission electron microscopy (TEM) showed that morphological characteristic changes of rat liver, including the number of lamellar bodies, grade of vacuolization and cell steatosis, were markedly attenuated in rats treated with naltrexone alone or in combination with chloroquine, in comparison with chloroquine‐treated rats. The results of liquid chromatography mass spectrometry (LC/MS) showed that the concentrations of phenylacetylglycine (PAG) and hippuric acid (HA) were significantly decreased and increased, respectively, in target groups. Besides, the concentration ratio of PAG/HA was significantly decreased. Spectrophotometry resulted in a notable decrease in alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities in target groups. The results from the molecular docking and molecular dynamic simulation studies demonstrated clear chloroquine interaction with the active site cavity of the µ opioid receptor. These data suggest that administration of naltrexone alone, or in combination with chloroquine, notably attenuates the side effects of chloroquine‐induced phospholipidosis, as well as demonstrating an increased probability of the endogenous opioid system involvement in chloroquine‐induced phospholipidosis in rat liver.